BlackRock Fund Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$208M Buy
4,855,274
+523,814
+12% +$21.3M 0.04% 613
2016
Q3
$179M Buy
4,331,460
+342,824
+9% +$14.4M 0.04% 612
2016
Q2
$159M Buy
3,988,636
+283,616
+8% +$10.2M 0.04% 636
2016
Q1
$125M Sell
3,705,020
-13,706
-0.4% -$427K 0.03% 775
2015
Q4
$126M Buy
3,718,726
+231,258
+7% +$7.23M 0.03% 785
2015
Q3
$104M Buy
3,487,468
+390,358
+13% +$12.2M 0.03% 874
2015
Q2
$104M Buy
3,097,110
+12,770
+0.4% +$416K 0.03% 959
2015
Q1
$95.1M Buy
3,084,340
+141,314
+5% +$4.09M 0.02% 1040
2014
Q4
$79.8M Buy
2,943,026
+298,084
+11% +$7.39M 0.02% 1129
2014
Q3
$65.6M Buy
2,644,942
+5,620
+0.2% +$137K 0.02% 1172
2014
Q2
$62.1M Sell
2,639,322
-25,994
-1% -$592K 0.02% 1256
2014
Q1
$61.3M Buy
2,665,316
+51,018
+2% +$1.2M 0.02% 1255
2013
Q4
$62.4M Buy
2,614,298
+238,504
+10% +$5.35M 0.02% 1224
2013
Q3
$47.8M Buy
2,375,794
+228,542
+11% +$4.49M 0.02% 1372
2013
Q2
$39.3M Hold
2,147,252
– – 0.01% 1403

Other funds holding IART

BlackRock Fund Advisors's IART Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Integra LifeSciences (IART) stake by 12% in Q4 2016, buying an estimated $21.3M and bringing the position to 4,855,274 shares worth $208M. The position accounts for 0.04% of the portfolio, ranked #613.

BlackRock Fund Advisors first reported a position in IART in Q2 2013 and has held it in 15 quarters since. 224 funds tracked by Wall St. Rank hold IART as of Q4 2016.

  • BlackRock Fund Advisors held 4,855,274 shares of Integra LifeSciences worth $208M as of Q4 2016.
  • BlackRock Fund Advisors bought 523,814 Integra LifeSciences shares in Q4 2016, an estimated $21.3M.
  • Integra LifeSciences made up 0.04% of BlackRock Fund Advisors's portfolio in Q4 2016, its #613 holding.
  • BlackRock Fund Advisors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 15 quarters since.
  • 224 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.